Developing Global Value Dossiers (GVDs) is one of the most complex and time-consuming steps in the market access process. Medical Affairs, HEOR, and Regulatory teams must synthesize large volumes of clinical, economic, and real-world evidence while meeting the requirements of multiple HTA bodies across global markets.

MadeAi delivers AI-powered GVD automation designed for life sciences teams, enabling faster evidence synthesis, structured content generation, and regulatory-ready dossier development across global markets.

Download the white paper on AI-Powered GVD Automation to see how life sciences teams can speed up dossier development and improve quality.